[Retracted] Analysis of Prognostic Factors and Treatment Modes of Patients with Recurrent Endometrial Carcinoma

Table 1

Clinicopathological data of REC patients (n (%) and mean ± SD).

Factors	Patients (n = 100)
Age (years)
<65	55 (55.00)
≥65	45 (45.00)
Average age (years)	64.25 ± 7.26
FIGO stage
I	68 (68.00)
II	17 (17.00)
III	10 (10.00)
IV	5 (5.00)
Radiotherapy and chemotherapy after primary surgery
No	26 (26.00)
Yes	74 (74.00)
Infiltrating muscularis
Without	20 (20.00)
<1/2	24 (24.00)
≥1/2	56 (56.00)
Pathological pattern
Endometrioid adenocarcinoma	78 (78.00)
Serous adenocarcinoma	22 (22.00)
Pathological grade
G1	28 (28.00)
G2	22 (22.00)
G3	50 (50.00)
DFI (months)
<12	48 (48.00)
≥12	52 (52.00)
Recurrence site
Pelvic cavity	40 (40.00)
Outside the pelvic cavity	60 (60.00)
Treatment mode after relapse
DLT	41 (41.00)
PC	59 (59.00)